Skip to main content

Advertisement

Table 4 Treatments and outcomes in patients with spontaneous bacterial peritonitis caused by Enterobacter species and Escherichia coli

From: Erratum to: Clinical characteristics and outcomes of spontaneous bacterial peritonitis caused by Enterobacter species versus Escherichia coli: a matched case-control study

Variable Enterobacter SBP (n = 32) E. coli SBP (n = 128) P
Initial empirical antimicrobial agent
 Cefotaxime 27 (84.4) 116 (90.6) 0.31
 Imipenem or meropenem 4 (12.4) 9 (7.0)  
 Cefazolin 1 (3.1) 0 (0)  
 Ceftazidime 0 (0) 1 (0.8)  
 Cefepime 0 (0) 1 (0.8)  
 Levofloxacin 0 (0) 1 (0.8)  
Appropriateness of initial therapy 27 (87.1) 109 (87.2) 1.00
Initial response to empirical treatmenta 26/32 (81.3) 95/117 (81.2) 0.995
Emergence of resistance during third-generation cephalosporin treatment 1/23 (4.3) 0/98 (0) 0.19
Duration of hospitalization, median days (IQR)
 Overall 20 (11–31) 16 (10–26) 0.28
 Survivors 22 (12–31) 16 (11–26) 0.41
Duration of antimicrobial use, median days (IQR)
 Overall 15 (11–25) 13 (8–16) 0.02
 Survivors 16 (13–29) 13 (10–16) 0.01
ICU care during admission 2 (6.2) 19 (14.8) 0.25
Mortality
 14-day mortality 7 (21.9) 25 (19.5) 0.77
 30-day mortality 12 (37.5) 37 (28.9) 0.35
 In-hospital mortality 12 (37.5) 28 (21.9) 0.07
  1. Values are n (%) unless otherwise indicated. IQR interquartile range, ICU intensive care unit
  2. aAscitic neutrophil decrease >25 % observed 48–72 h after initiating antimicrobials